Variant report

Variant	nsv1027019
Chromosome Location	chr9:44176330-44855725
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:2674)
CpG islands
(count:732)
Chromatin interactive
region (count:1)
LncRNA
region (count:31)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:2674 , 50 per page) page: 1 2 3 4 5 6 7 ... 54

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr9:44799676-44800004	HepG2	liver:	n/a	n/a
2	ARID3A	chr9:44781098-44781371	K562	blood:	n/a	n/a
3	ATF1	chr9:44781241-44781724	K562	blood:	n/a	n/a
4	BACH1	chr9:44227257-44227630	K562	blood:	n/a	n/a
5	BACH1	chr9:44227184-44227631	H1-hESC	embryonic stem cell:	n/a	n/a
6	BATF	chr9:44556841-44557602	GM12878	blood:	n/a	n/a
7	BATF	chr9:44265544-44265770	GM12878	blood:	n/a	n/a
8	BATF	chr9:44306115-44306341	GM12878	blood:	n/a	n/a
9	BATF	chr9:44292256-44292632	GM12878	blood:	n/a	n/a
10	BATF	chr9:44340761-44341046	GM12878	blood:	n/a	n/a
11	BATF	chr9:44645234-44645529	GM12878	blood:	n/a	chr9:44645403-44645414
12	BATF	chr9:44577809-44578267	GM12878	blood:	n/a	chr9:44577967-44577975
13	BATF	chr9:44245139-44246113	GM12878	blood:	n/a	n/a
14	BATF	chr9:44836556-44836749	GM12878	blood:	n/a	n/a
15	BATF	chr9:44742136-44742432	GM12878	blood:	n/a	n/a
16	BATF	chr9:44401104-44402763	GM12878	blood:	n/a	n/a
17	BATF	chr9:44342310-44342546	GM12878	blood:	n/a	n/a
18	BATF	chr9:44577860-44578259	GM12878	blood:	n/a	chr9:44577967-44577975
19	BATF	chr9:44528122-44528281	GM12878	blood:	n/a	n/a
20	BATF	chr9:44539661-44540230	GM12878	blood:	n/a	n/a
21	BATF	chr9:44401959-44402428	GM12878	blood:	n/a	n/a
22	BATF	chr9:44382132-44382329	GM12878	blood:	n/a	n/a
23	BATF	chr9:44533431-44533653	GM12878	blood:	n/a	n/a
24	BATF	chr9:44212515-44212942	GM12878	blood:	n/a	chr9:44212712-44212723
25	BATF	chr9:44550562-44550766	GM12878	blood:	n/a	n/a
26	BATF	chr9:44605098-44605838	GM12878	blood:	n/a	n/a
27	BATF	chr9:44292314-44292554	GM12878	blood:	n/a	n/a
28	BATF	chr9:44341525-44341789	GM12878	blood:	n/a	chr9:44341638-44341649
29	BATF	chr9:44245375-44245745	GM12878	blood:	n/a	n/a
30	BATF	chr9:44243686-44243967	GM12878	blood:	n/a	n/a
31	BATF	chr9:44434613-44435054	GM12878	blood:	n/a	n/a
32	BATF	chr9:44469306-44469638	GM12878	blood:	n/a	n/a
33	BATF	chr9:44606159-44606345	GM12878	blood:	n/a	n/a
34	BATF	chr9:44280534-44280732	GM12878	blood:	n/a	n/a
35	BATF	chr9:44212521-44212907	GM12878	blood:	n/a	chr9:44212712-44212723
36	BATF	chr9:44355328-44355568	GM12878	blood:	n/a	n/a
37	BATF	chr9:44434645-44435048	GM12878	blood:	n/a	n/a
38	BATF	chr9:44280452-44280759	GM12878	blood:	n/a	n/a
39	BATF	chr9:44605070-44605809	GM12878	blood:	n/a	n/a
40	BATF	chr9:44550459-44550750	GM12878	blood:	n/a	n/a
41	BATF	chr9:44305341-44305592	GM12878	blood:	n/a	n/a
42	BATF	chr9:44435839-44436055	GM12878	blood:	n/a	n/a
43	BATF	chr9:44367127-44367454	GM12878	blood:	n/a	n/a
44	BATF	chr9:44306841-44307126	GM12878	blood:	n/a	n/a
45	BATF	chr9:44556907-44557469	GM12878	blood:	n/a	n/a
46	BATF	chr9:44419769-44419966	GM12878	blood:	n/a	n/a
47	BATF	chr9:44176537-44176725	GM12878	blood:	n/a	n/a
48	BATF	chr9:44645280-44645491	GM12878	blood:	n/a	chr9:44645403-44645414
49	BATF	chr9:44552199-44552435	GM12878	blood:	n/a	n/a
50	BATF	chr9:44355408-44355626	GM12878	blood:	n/a	n/a

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr9:44422602-44422652	HMEC	breast:	n/a
2	chr9:44401998-44402048	MCF10A-Er-Src	breast:	n/a
3	chr9:44401998-44402048	SK-N-MC	brain:	n/a
4	chr9:44745070-44745120	NHDF-neo	bronchial:	n/a
5	chr9:44313114-44313164	H1-hESC	embryonic stem cell:	embryo
6	chr9:44743856-44743906	AoSMC	blood vessel:	n/a
7	chr9:44227339-44227389	Caco-2	colon:	n/a
8	chr9:44744257-44744307	HCPEpiC	choroid plexus:	n/a
9	chr9:44227210-44227260	MCF10A-Er-Src	breast:	n/a
10	chr9:44745070-44745120	AG04450	lung:	fetal
11	chr9:44401998-44402048	NT2-D1	testis:	n/a
12	chr9:44744257-44744307	GM12891	blood:	n/a
13	chr9:44744257-44744307	K562	blood:	n/a
14	chr9:44227339-44227389	NHDF-neo	bronchial:	n/a
15	chr9:44745070-44745120	HIPEpiC	eye:	n/a
16	chr9:44313114-44313164	HNPCEpiC	eye:	n/a
17	chr9:44841495-44841545	H1-hESC	embryonic stem cell:	embryo
18	chr9:44745070-44745120	GM12891	blood:	n/a
19	chr9:44842398-44842448	AG10803	skin:	n/a
20	chr9:44420179-44420229	HCM	heart:	n/a
21	chr9:44742086-44742136	AG09309	skin:	n/a
22	chr9:44227339-44227389	U87	brain:	n/a
23	chr9:44422602-44422652	IMR90	lung:	fetal
24	chr9:44742086-44742136	GM19239	blood:	n/a
25	chr9:44401998-44402048	HPAEpiC	pulmonary alveolar:	n/a
26	chr9:44227210-44227260	NHBE	bronchial:	n/a
27	chr9:44313114-44313164	HCT-116	colon:	n/a
28	chr9:44422602-44422652	T-47D	breast:	n/a
29	chr9:44841495-44841545	HNPCEpiC	eye:	n/a
30	chr9:44742086-44742136	GM06990	blood:	n/a
31	chr9:44745070-44745120	PFSK-1	brain:	n/a
32	chr9:44745070-44745120	AG10803	skin:	n/a
33	chr9:44313114-44313164	IMR90	lung:	fetal
34	chr9:44742086-44742136	HL-60	blood:	n/a
35	chr9:44744257-44744307	IMR90	lung:	fetal
36	chr9:44743856-44743906	HCF	heart:	n/a
37	chr9:44842398-44842448	SK-N-SH	brain:	n/a
38	chr9:44743856-44743906	HPAEpiC	pulmonary alveolar:	n/a
39	chr9:44744257-44744307	NHBE	bronchial:	n/a
40	chr9:44313114-44313164	HCM	heart:	n/a
41	chr9:44842398-44842448	K562	blood:	n/a
42	chr9:44313114-44313164	HRPEpiC	eye:	n/a
43	chr9:44313114-44313164	HEEpiC	esophagus:	n/a
44	chr9:44743856-44743906	GM06990	blood:	n/a
45	chr9:44227339-44227389	SK-N-SH	brain:	n/a
46	chr9:44313114-44313164	HL-60	blood:	n/a
47	chr9:44227210-44227260	ECC-1	luminal epithelium:	n/a
48	chr9:44422602-44422652	GM12891	blood:	n/a
49	chr9:44842398-44842448	GM19239	blood:	n/a
50	chr9:44420179-44420229	U87	brain:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:107699957..107700478-chr9:44227430..44227950,2	MCF-7	breast:

(count:31 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-FAM75A6-14	chr9:44672800-44672959	NONHSAT131392
2	lnc-CNTNAP3B-1	chr9:44384585-44387483	ENSG00000229311
3	lnc-RP11-160N1.10.1-1	chr9:44823714-44823845	ENSG00000231248.2
4	lnc-RP11-160N1.10.1-1	chr9:44828088-44828239	ENSG00000231248.2
5	lnc-FAM75A6-14	chr9:44674678-44674747	NONHSAT131392
6	lnc-RP11-160N1.10.1-1	chr9:44835387-44835521	ENSG00000231248.2
7	lnc-FAM75A6-2	chr9:44181550-44181732	XLOC_007697
8	lnc-FAM75A6-13	chr9:44477549-44477882	NONHSAT131390
9	lnc-RP11-160N1.10.1-2	chr9:44402460-44402515	ENSG00000237357
10	lnc-FAM75A6-3	chr9:44260052-44260139	ENSG00000233424
11	lnc-CNTNAP3B-1	chr9:44391077-44391416	NR_046203
12	lnc-RP11-160N1.10.1-4	chr9:44768084-44768235	NONHSAT131393
13	lnc-FAM75A6-14	chr9:44673720-44673889	NONHSAT131392
14	lnc-CNTNAP3B-1	chr9:44391077-44391705	ENSG00000229311
15	lnc-FAM75A6-13	chr9:44478194-44478456	NONHSAT131390
16	lnc-RP11-160N1.10.1-1	chr9:44834508-44834806	ENSG00000231248.2
17	lnc-FAM75A6-3	chr9:44260052-44260139	ENSG00000233424.2
18	lnc-RP11-160N1.10.1-5	chr9:44562093-44562588	NONHSAT131391
19	lnc-FAM75A6-3	chr9:44260422-44263319	ENSG00000233424
20	lnc-CNTNAP3B-1	chr9:44387768-44387853	ENSG00000229311
21	lnc-FAM75A6-3	chr9:44260422-44263319	ENSG00000233424.2
22	lnc-RP11-160N1.10.1-4	chr9:44763709-44763841	NONHSAT131393
23	lnc-RP11-160N1.10.1-4	chr9:44774504-44774802	NONHSAT131393
24	lnc-FAM75A6-3	chr9:44256189-44256817	ENSG00000233424
25	lnc-FAM75A6-3	chr9:44256580-44256817	ENSG00000233424.2
26	lnc-CNTNAP3B-1	chr9:44387768-44387853	NR_046203
27	lnc-FAM75A6-14	chr9:44676388-44676450	NONHSAT131392
28	lnc-CNTNAP3B-1	chr9:44387387-44387483	NR_046203
29	lnc-RP11-160N1.10.1-4	chr9:44775383-44775517	NONHSAT131393
30	lnc-RP11-160N1.10.1-2	chr9:44403060-44403260	ENSG00000237357
31	lnc-FAM75A6-2	chr9:44182692-44183417	XLOC_007697

No data

Variant related genes	Relation type
ENSG00000223664	TF binding region
ATP5A1P6	TF binding region
ENSG00000231248	TF binding region
ENSG00000228920	TF binding region
ENSG00000230245	TF binding region
ENSG00000227353	TF binding region
ENSG00000216829	TF binding region
ENSG00000268708	TF binding region
ENSG00000212952	TF binding region
ENSG00000238933	TF binding region
ENSG00000204818	TF binding region
ENSG00000237357	TF binding region
RBPJP6	TF binding region
ENSG00000204816	TF binding region
ENSG00000233424	TF binding region
ENSG00000229311	TF binding region
ENSG00000268234	TF binding region
ENSG00000223664	CpG island
ATP5A1P6	CpG island
ENSG00000231248	CpG island
ENSG00000228920	CpG island
ENSG00000230245	CpG island
ENSG00000227353	CpG island
ENSG00000216829	CpG island
ENSG00000268708	CpG island
ENSG00000212952	CpG island
ENSG00000238933	CpG island
ENSG00000204818	CpG island
ENSG00000237357	CpG island
RBPJP6	CpG island
ENSG00000204816	CpG island
ENSG00000233424	CpG island
ENSG00000229311	CpG island
ENSG00000268234	CpG island

Extended variants
information (count: 2692 )
Associated
traits (count: 71 )

Variant overlapped rSNPs/rCNVs (count:2692 , 50 per page) page: 1 2 3 4 5 6 7 ... 54

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs576268256	chr9:44176333-44176334	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs542646214	chr9:44176362-44176363	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs180984828	chr9:44176365-44176366	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs28510921	chr9:44176398-44176399	Bivalent Enhancer Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs576207225	chr9:44176416-44176417	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs544002979	chr9:44176460-44176461	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs200772436	chr9:44176468-44176469	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs201915544	chr9:44176523-44176524	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs141813480	chr9:44176524-44176525	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs541743648	chr9:44176547-44176548	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs377093035	chr9:44176602-44176603	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs560035600	chr9:44176603-44176604	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs530003517	chr9:44176646-44176647	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs532409785	chr9:44176668-44176669	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs548567748	chr9:44176685-44176686	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs570025180	chr9:44176693-44176694	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs530929539	chr9:44176694-44176695	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs552290176	chr9:44176711-44176712	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs571090517	chr9:44176727-44176728	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs372373664	chr9:44176742-44176743	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs553771079	chr9:44176744-44176745	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs28436953	chr9:44176772-44176773	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs535824258	chr9:44176785-44176786	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs62540973	chr9:44176796-44176797	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs28634151	chr9:44176803-44176804	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs28708820	chr9:44176804-44176805	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs554569082	chr9:44176813-44176814	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs576170859	chr9:44176832-44176833	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs184404561	chr9:44176923-44176924	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs571554127	chr9:44176930-44176931	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs67198118	chr9:44176931-44176932	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs111437708	chr9:44176934-44176935	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs577504142	chr9:44176953-44176954	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs541623546	chr9:44176976-44176977	Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs559749521	chr9:44177058-44177059	Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs530447137	chr9:44177109-44177110	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs541826047	chr9:44177110-44177111	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs563687616	chr9:44177112-44177113	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs146083505	chr9:44177117-44177118	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs552247311	chr9:44177133-44177134	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs564278888	chr9:44177147-44177148	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs532132054	chr9:44177149-44177150	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs547570305	chr9:44177174-44177175	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs565806476	chr9:44177183-44177184	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs548317439	chr9:44177188-44177189	Bivalent Enhancer Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs568510901	chr9:44177244-44177245	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs537163720	chr9:44177277-44177278	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs144810899	chr9:44177318-44177319	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs571307526	chr9:44177336-44177337	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs569647769	chr9:44177353-44177354	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:71)

Disease	PMID	Source
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17133270	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Urothelial carcinoma	21177765	CNVD
Renal cell carcinoma	21668985	CNVD
Autism	22495311	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Cancer	16751803	CNVD
Myelofibrosis	22110671	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
Oral cancer	21386901	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21509527	CNVD
Sezary syndrome	18413736	CNVD
Schizophrenia	21346763	CNVD
Breast cancer	21990379	CNVD
Astrocytoma	22246337	CNVD
Lung adenocarcinoma	17086460	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
early-passage human iPS cells	21368824	CNVD
Lung cancer	17086460	CNVD
Rhabdomyosarcoma	16790082	CNVD
Schizophrenia	20967226	CNVD
Schizophrenia	23813976	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:250 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:44165800-44180000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr9:44176200-44176400	Enhancers	Adipose Nuclei	Adipose
3	chr9:44176200-44176800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
4	chr9:44176800-44177000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
5	chr9:44176800-44177000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
6	chr9:44177000-44177200	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
7	chr9:44180000-44180200	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
8	chr9:44180200-44187800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr9:44183400-44183600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
10	chr9:44183400-44183600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
11	chr9:44187400-44187800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
12	chr9:44187800-44188000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr9:44187800-44188000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
14	chr9:44188000-44188400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
15	chr9:44188000-44188800	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr9:44188000-44189000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
17	chr9:44188200-44188400	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
18	chr9:44188200-44188800	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
19	chr9:44188400-44188800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr9:44195200-44196000	Enhancers	Adipose Nuclei	Adipose
21	chr9:44213600-44214200	Enhancers	ES-I3 Cell Line	embryonic stem cell
22	chr9:44214000-44214400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
23	chr9:44214000-44214400	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
24	chr9:44227000-44227200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
25	chr9:44227000-44227200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
26	chr9:44227000-44227200	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr9:44227000-44227200	Enhancers	Adipose Nuclei	Adipose
28	chr9:44227000-44227200	Enhancers	Stomach Smooth Muscle	stomach
29	chr9:44227000-44227200	Enhancers	NHEK	skin
30	chr9:44227000-44227600	Active TSS	A549	lung
31	chr9:44227200-44227400	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
32	chr9:44227200-44227400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr9:44227200-44227400	Active TSS	HUES48 Cell Line	embryonic stem cell
34	chr9:44227200-44227400	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
35	chr9:44227200-44227400	Flanking Bivalent TSS/Enh	Primary T helper naive cells fromperipheralblood	blood
36	chr9:44227200-44227400	Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
37	chr9:44227200-44227400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
38	chr9:44227200-44227400	Active TSS	Brain Cingulate Gyrus	brain
39	chr9:44227200-44227400	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
40	chr9:44227200-44227400	Active TSS	Duodenum Smooth Muscle	Duodenum
41	chr9:44227200-44227400	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
42	chr9:44227200-44227400	Active TSS	Pancreas	Pancrea
43	chr9:44227200-44227400	Enhancers	Skeletal Muscle Female	skeletal muscle
44	chr9:44227200-44227600	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
45	chr9:44227200-44227600	Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
46	chr9:44227200-44227600	Active TSS	H9 Cell Line	embryonic stem cell
47	chr9:44227200-44227600	Active TSS	iPS DF 6.9 Cell Line	embryonic stem cell
48	chr9:44227200-44227600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr9:44227200-44227600	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
50	chr9:44227200-44227600	Active TSS	Breast Myoepithelial Primary Cells	Breast

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links